Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise su
. Other Events. On January 27, 2026, Intellia announced that the U.S. Food and Drug Administration (“FDA”) has removed the clinical hold on the investigational
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 27, 2026, titled “Intellia Therapeutics Announces FDA L